160 related articles for article (PubMed ID: 9438024)
1. Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.
Curtin ML; Davidsen SK; Heyman HR; Garland RB; Sheppard GS; Florjancic AS; Xu L; Carrera GM; Steinman DH; Trautmann JA; Albert DH; Magoc TJ; Tapang P; Rhein DA; Conway RG; Luo G; Denissen JF; Marsh KC; Morgan DW; Summers JB
J Med Chem; 1998 Jan; 41(1):74-95. PubMed ID: 9438024
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
Carceller E; Merlos M; Giral M; Balsa D; GarcĂa-Rafanell J; Forn J
J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.
Stewart AG; Grigoriadis G
J Lipid Mediat; 1991 Nov; 4(3):299-308. PubMed ID: 1662547
[TBL] [Abstract][Full Text] [Related]
4. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
[No Abstract] [Full Text] [Related]
5. UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo.
Alabaster VA; Keir RF; Parry MJ; de Souza RN
Agents Actions Suppl; 1991; 34():221-7. PubMed ID: 1793066
[TBL] [Abstract][Full Text] [Related]
6. In vitro platelet-activating factor receptor binding inhibitory activity of pinusolide derivatives: a structure-activity study.
Han BH; Yang HO; Kang YH; Suh DY; Go HJ; Song WJ; Kim YC; Park MK
J Med Chem; 1998 Jul; 41(14):2626-30. PubMed ID: 9651167
[TBL] [Abstract][Full Text] [Related]
7. Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists.
Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Bryant M; Lau J
Bioorg Med Chem Lett; 2006 Mar; 16(6):1544-8. PubMed ID: 16380251
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacology of a novel class of long-lasting PAF receptor antagonists.
Houlihan WJ; Cheon SH; Handley DA; Larson DA
J Lipid Mediat; 1991; 3(1):91-9. PubMed ID: 1662991
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist.
Albert DH; Magoc TJ; Tapang P; Luo G; Morgan DW; Curtin M; Sheppard GS; Xu L; Heyman HR; Davidsen SK; Summers JB; Carter GW
Eur J Pharmacol; 1997 Apr; 325(1):69-80. PubMed ID: 9151941
[TBL] [Abstract][Full Text] [Related]
10. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Imai K; Inamura N; Asano M; Hatori C; Katayama A; Oku T; Tanaka H
J Med Chem; 1998 Feb; 41(4):564-78. PubMed ID: 9484506
[TBL] [Abstract][Full Text] [Related]
11. Novel antagonists of platelet-activating factor. 2. Synthesis and structure-activity relationships of potent and long-acting heterofused [1,5]benzodiazepine and [1,4]diazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
Fray MJ; Bull DJ; Cooper K; Parry MJ; Stefaniak MH
J Med Chem; 1995 Sep; 38(18):3524-35. PubMed ID: 7658439
[TBL] [Abstract][Full Text] [Related]
12. 1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives.
Cooper K; Fray MJ; Parry MJ; Richardson K; Steele J
J Med Chem; 1992 Aug; 35(17):3115-29. PubMed ID: 1507200
[TBL] [Abstract][Full Text] [Related]
13. Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
Parlow JJ; Burney MW; Case BL; Girard TJ; Hall KA; Hiebsch RR; Huff RM; Lachance RM; Mischke DA; Rapp SR; Woerndle RS; Ennis MD
Bioorg Med Chem Lett; 2009 Aug; 19(16):4657-63. PubMed ID: 19604694
[TBL] [Abstract][Full Text] [Related]
14. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.
Balsa D; Merlos M; Giral M; Ferrando R; Garcia-Rafanell J; Forn J
Drugs Exp Clin Res; 1997; 23(5-6):191-9. PubMed ID: 9515229
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor.
Quan ML; Lam PY; Han Q; Pinto DJ; He MY; Li R; Ellis CD; Clark CG; Teleha CA; Sun JH; Alexander RS; Bai S; Luettgen JM; Knabb RM; Wong PC; Wexler RR
J Med Chem; 2005 Mar; 48(6):1729-44. PubMed ID: 15771420
[TBL] [Abstract][Full Text] [Related]
16. Chemistry and pharmacology of PAF antagonists. Evaluation of changes at potential metabolism sites on activity and duration of activity.
Handley DA; Houlihan WJ; Tomesch JC; Farley C; Deacon RW; Koletar JM; Prashad M; Hughes JW; Jaeggi C
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():367-70. PubMed ID: 2546390
[No Abstract] [Full Text] [Related]
17. Discovery of novel 2,8-diazaspiro[4.5]decanes as orally active glycoprotein IIb-IIIa antagonists.
Mehrotra MM; Heath JA; Smyth MS; Pandey A; Rose JW; Seroogy JM; Volkots DL; Nannizzi-Alaimo L; Park GL; Lambing JL; Hollenbach SJ; Scarborough RM
J Med Chem; 2004 Apr; 47(8):2037-61. PubMed ID: 15056002
[TBL] [Abstract][Full Text] [Related]
18. Metabolism-based identification of a potent thrombin receptor antagonist.
Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee W; Kao G; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Smith-Torhan A; Alton K; Bryant M; Hsieh Y; Lau J; Palamanda J
J Med Chem; 2007 Jan; 50(1):129-38. PubMed ID: 17201416
[TBL] [Abstract][Full Text] [Related]
19. [PAF-antagonists with phospholipid structure. 4. Alkylcarbamoylphospholipids with heteroarene and heterocyclase head groups and variation of the P-N-distance; synthesis, characterization and structure-activity relationship].
Kertscher HP; Schmidt B; Ostermann G
Pharmazie; 1992 Mar; 47(3):172-4. PubMed ID: 1615020
[TBL] [Abstract][Full Text] [Related]
20. Novel antagonists of platelet-activating factor. 1. Synthesis and structure-activity relationships of benzodiazepine and benzazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
Fray MJ; Cooper K; Parry MJ; Richardson K; Steele J
J Med Chem; 1995 Sep; 38(18):3514-23. PubMed ID: 7658438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]